Compugroup Medical Se Stock Performance

CMPVF Stock  USD 29.89  5.10  14.58%   
The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CompuGroup Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding CompuGroup Medical is expected to be smaller as well. CompuGroup Medical has an expected return of -0.37%. Please make sure to confirm CompuGroup Medical standard deviation, skewness, as well as the relationship between the Skewness and day typical price , to decide if CompuGroup Medical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days CompuGroup Medical SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow75.9 M
Total Cashflows From Investing Activities-164 M
  

CompuGroup Medical Relative Risk vs. Return Landscape

If you would invest  3,800  in CompuGroup Medical SE on December 29, 2023 and sell it today you would lose (811.00) from holding CompuGroup Medical SE or give up 21.34% of portfolio value over 90 days. CompuGroup Medical SE is currently producing negative expected returns and takes up 2.1091% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than CompuGroup, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon CompuGroup Medical is expected to under-perform the market. In addition to that, the company is 3.71 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.24 per unit of volatility.

CompuGroup Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuGroup Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CompuGroup Medical SE, and traders can use it to determine the average amount a CompuGroup Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1749

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCMPVF

Estimated Market Risk

 2.11
  actual daily
18
82% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average CompuGroup Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CompuGroup Medical by adding CompuGroup Medical to a well-diversified portfolio.

CompuGroup Medical Fundamentals Growth

CompuGroup Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CompuGroup Medical, and CompuGroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuGroup Pink Sheet performance.

About CompuGroup Medical Performance

To evaluate CompuGroup Medical Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when CompuGroup Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare CompuGroup Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand CompuGroup Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents CompuGroup's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.

Things to note about CompuGroup Medical performance evaluation

Checking the ongoing alerts about CompuGroup Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CompuGroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
CompuGroup Medical generated a negative expected return over the last 90 days
The company has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 1.32, which is about average as compared to similar companies. CompuGroup Medical has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CompuGroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CompuGroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CompuGroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CompuGroup to invest in growth at high rates of return. When we think about CompuGroup Medical's use of debt, we should always consider it together with cash and equity.
About 50.0% of CompuGroup Medical shares are held by company insiders
Evaluating CompuGroup Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate CompuGroup Medical's pink sheet performance include:
  • Analyzing CompuGroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuGroup Medical's stock is overvalued or undervalued compared to its peers.
  • Examining CompuGroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating CompuGroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuGroup Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of CompuGroup Medical's pink sheet. These opinions can provide insight into CompuGroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating CompuGroup Medical's pink sheet performance is not an exact science, and many factors can impact CompuGroup Medical's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for CompuGroup Pink Sheet analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Please note, there is a significant difference between CompuGroup Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if CompuGroup Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CompuGroup Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.